Up to eleven percent of women of reproductive age could have endometriosis, an undiagnosed painful condition that makes the menstrual cycle harder and is linked to infertility. It’s caused by uterine tissue growth outside of the uterus and there is no cure. An injection therapy became...
You are here
Neurocrine Biosciences, Inc.
Company Information
Address
Neurocrine Biosciences, Inc.
12790 El Camino Real
San Diego, CA
92130
United States
Information
UEI: N/A
# of Employees: N/A
Ownership Information
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Brain-penetrating H-3 Receptor Agonists for Insomnia
Amount: $136,412.00DESCRIPTION (PROVIDED BY APPLICANT): Insomnia is a complaint of poor sleep quality which is often associated with daytime sequelae that include fatigue, irritability, impaired memory, decreased concen ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health -
Novel non-peptide antagonist of the MCH receptor
Amount: $0.00DESCRIPTION (provided by applicant): Obesity is a rapidly advancing worldwide epidemic. Within the United States alone, 60% of the population is considered to be overweight. While new treatments for o ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
Novel non-peptide antagonist of the MCH receptor
Amount: $946,531.00DESCRIPTION (provided by applicant): Obesity is a rapidly advancing worldwide epidemic. Within the United States alone, 60% of the population is considered to be overweight. While new treatments for o ...
SBIRPhase II2003Department of Health and Human Services National Institutes of Health -
NOVEL NON-PEPTIDE AGONISTS OF THE MELANOCORTIN RECEPTOR
Amount: $139,336.00DESCRIPTION (Scanned from the Applicant's Abstract): Obesity is the most common contributing factor to illness worldwide, including such diseases as Type II diabetes, coronary heart disea ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
SELECTIVE CRF ANTAGONISTS FOR BOWEL DISORDERS
Amount: $139,497.00Corticotropin releasing factor (CRF) controls the anterior pituitary secretion of adrenocorticotropin and other propiomelanocortin products. CRF also coordinates the endocrine, behavioral and autonomi ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
A SCREENING LIBRARY FOR PEPTIDE-ACTIVATED GPCR'S
Amount: $1,527,446.00One subset of the G-protein coupled receptor (GPCR) superfamily is that which is activated by a peptide carrying an obligatory positively charged residue (GPCR-PA+). This subclass is exemplified by re ...
SBIRPhase II2002Department of Health and Human Services National Institutes of Health -
A SCREENING LIBRARY FOR PEPTIDE-ACTIVATED GPCR'S
Amount: $0.00One subset of the G-protein coupled receptor (GPCR) superfamily is that which is activated by a peptide carrying an obligatory positively charged residue (GPCR-PA+). This subclass is exemplified by re ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
CORTICOTROPIN RELEASING FACTOR RECEPTOR FUNCTION IN CNS
Amount: $170,479.00DESCRIPTION (provided by applicant): Corticotropin releasing factor (CRF) receptors are involved in the stress response; CRF produces generalized arousal and anxiety-like behaviors in rodents. Two rel ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
NOVEL CRF ANTAGONISTS FOR INFLAMMATION AND PAIN
Amount: $130,048.00Inflammation and pain affect large and ever-increasing patient populations. Narcotics, corticosteroids, and NSAIDs are effective, but they are associated with tremendous adverse effects which now acco ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
NONPEPTIDE ANTAGONISTS OF CCR-7 FOR IMMUNOSUPPRESSION
Amount: $137,959.00Multiple sclerosis (MS) is a chronic autoimmune disease that afflicts roughly 300,000 Americans. The disease involves immune-mediated inflammation of the central nervous system (CNS) which leads to p ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health
